Previous 10 | Next 10 |
IQVIA Holdings (IQV) Q3 2022 Earnings Conference Call October 26, 2022, 09:00 AM ET Company Participants Nick Childs - Senior Vice President, Investor Relations and Treasurer Ari Bousbib - Chairman and Chief Executive Officer Ron Bruehlman - Executive Vice Presid...
The following slide deck was published by IQVIA Holdings Inc. in conjunction with their 2022 Q3 earnings call. For further details see: IQVIA Holdings Inc. 2022 Q3 - Results - Earnings Call Presentation
IQVIA press release ( NYSE: IQV ): Q3 Non-GAAP EPS of $2.48 beats by $0.10 . Revenue of $3.56B (+5.0% Y/Y) beats by $20M . Adjusted EBITDA of $814 million increased 11.8 percent year-over-year. R&D Solutions quarterly bookings of over $2.5 billion; excl...
Revenue of $3,562 million grew 5.0 percent year-over-year on a reported basis and 10.5 percent at constant currency GAAP Net Income of $283 million grew 8.4 percent year-over-year Adjusted EBITDA of $814 million increased 11.8 percent year-over-year GAAP ...
IQVIA ( NYSE: IQV ) is scheduled to announce Q3 earnings results on Wednesday, October 26th, before market open. The consensus EPS Estimate is $2.38 (+9.7% Y/Y) and the consensus Revenue Estimate is $3.54B (+4.4% Y/Y). Over the last 2 years, IQV has beaten EPS estima...
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Credit Suisse Annual Healthcare Conference in Rancho Palos Verdes on Tuesday, November 8, 2022 at 12:10 p.m. ET (9:10 a.m. ...
Q² Solutions, a wholly owned subsidiary of IQVIA and a leading global clinical trial laboratory services organization, today announced the launch of the first self-collection safety lab panel for U.S. clinical trial participants by a leading global clinical trial laboratory. De...
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its third-quarter 2022 financial results before the market opens on Wednesday, October 26, 2022. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The ea...
IQVIA becomes first DCT program to demonstrate commitment to data protection in Europe IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and contract services to the life sciences industry, today announced its Decentralized Clinical Tria...
Summary IQVIA Holdings Inc. bottomed on June 16 and has since rallied 28% in a breakout attempt that finally failed. IQVIA Holdings stock is a strong leader in its industry, and despite some recent weakness, has significantly outperformed the broader healthcare sector. With 11...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 10:00:13 ET Jailendra Singh from Truist Financial issued a price target of $300.00 for IQV on 2024-07-23 09:26:00. The adjusted price target was set to $300.00. At the time of the announcement, IQV was trading at $240.265. The overall price target consensus is...
2024-07-23 10:00:11 ET Elizabeth Anderson from Evercore ISI issued a price target of $270.00 for IQV on 2024-07-23 08:59:00. The adjusted price target was set to $270.00. At the time of the announcement, IQV was trading at $239.5. The overall price target consensus is at...
2024-07-23 07:00:06 ET Luke Sergott from Barclays issued a price target of $275.00 for IQV on 2024-07-23 05:25:00. The adjusted price target was set to $275.00. At the time of the announcement, IQV was trading at $245.23. The overall price target consensus is at $273.93 ...